1
Supplemental Digital Content 1 to manuscript:
Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid Dependent Patients Undergoing HIV Treatment
Brandon Aden, MD, MPH
1,2Allison Dunning, MS
2Bohdan Nosyk, PhD
3,4Eve Wittenberg, PhD
5Jeremy W. Bray, PhD
6Bruce R. Schackman, PhD
1,21
Department of Medicine, Weill Cornell Medical College, New York, NY
2Department of
Healthcare Policy and Research, Weill Cornell Medical College, New York, NY;
3British Columbia
Centre for Excellence in HIV/AIDS, Vancouver, British Columbia;
4Faculty of Health Sciences,
Simon Fraser University, Burnaby, British Columbia;
5Center for Health Decision Science,
Harvard School of Public Health, Boston, MA;
6Department of Economics, The University of
North Carolina at Greensboro, Greensboro, NC
2
Table. Full Multivariate Linear Model of SF6D Scores for BHIVES Cohort
Model variable Estimate p-value
Intercept 0.738
Age 50+ ref
Age 40-49 0.002 0.82
30-39 0.027 0.08
Age <30 -0.043 0.17
Male ref
Female -0.036 <0.01
Asian/Pacific Islander/Native American ref
African American -0.070 <0.01
Caucasian -0.021 0.38
Hispanic -0.072 <0.01
Not married ref
Married 0.025 0.08
Not stably housed ref
Stably Housed 0.023 0.02
Not working ref
Working 0.067 <0.01
Not facing criminal charges and not on parole ref
Facing criminal charges or on parole -0.028 0.01
CD4 Count>350 cells/μL ref
CD4 Count ≤350 cells/μL -0.011 0.23
Not on ART ref
On ART with poor adherence 0.022 0.26
On ART with good adherence 0.082 <0.01
Not using other drugs Ref
Using other drugs‡ -0.028 0.02
Not using illicit opioids Ref
Using illicit opioids 0.000 0.98
Not in Buprenorphine treatment ref
Buprenorphine treatment 0.026 0.03
On ART with poor adherence, using illicit opioids -0.049 0.04 On ART with good adherence, using illicit opioids -0.067 <0.01
‡Includes cocaine (includes crack cocaine), barbiturates, sedative/hypnotics, amphetamines (includes methamphetamines), hallucinogens, and inhalants
